These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38303536)

  • 21. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
    Mahapatra DK; Bharti SK; Asati V; Singh SK
    Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flexibility in the bridge of chalcone derivatives is important for the inhibition of cellular growth.
    Stantliff TM; Hill A; Kuo ME; Neal HE; Harrod TC; Goens K; Mashuta M; Christianson AM; Krzysiak AJ
    Bioorg Med Chem Lett; 2023 Oct; 95():129467. PubMed ID: 37666364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Chalcone Derivatives Containing 2,4-Dichlorobenzenesulfonamide Moiety with Anticancer and Antioxidant Properties.
    Bułakowska A; Sławiński J; Hering A; Gucwa M; Ochocka JR; Hałasa R; Balewski Ł; Stefanowicz-Hajduk J
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.
    Liu W; He M; Li Y; Peng Z; Wang G
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):9-38. PubMed ID: 34894980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationships reveal a 2-furoyloxychalcone as a potent cytotoxic and apoptosis inducer for human U-937 and HL-60 leukaemia cells.
    Del Rosario H; Saavedra E; Brouard I; González-Santana D; García C; Spínola-Lasso E; Tabraue C; Quintana J; Estévez F
    Bioorg Chem; 2022 Oct; 127():105926. PubMed ID: 35717804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the Synthetic Chemistry of Phenyl-3-(5-aryl-2-furyl)- 2-propen-1-ones as Urease Inhibitors: Mechanistic Approach through Urease Inhibition, Molecular Docking and Structure-Activity Relationship.
    Fatima M; Aslam S; Zafar AM; Irfan A; Khan MA; Ashraf M; Faisal S; Noreen S; Shazly GA; Shah BR; Bin Jardan YA
    Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
    Alswah M; Bayoumi AH; Elgamal K; Elmorsy A; Ihmaid S; Ahmed HEA
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29280968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review on the Synthesis and Anticancer Potentials of Imidazothiazole Derivatives.
    Kamboj P; Mahore A; Husain A; Shaquiquzzaman M; Alam MM; Amir M
    Mini Rev Med Chem; 2023; 23(17):1733-1759. PubMed ID: 36722483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Quinazoline-Chalcone and Quinazolinone-Chalcone Hybrids: A Promising Combination for Biological Activity.
    Mass EB; Duarte GV; Russowsky D
    Mini Rev Med Chem; 2021; 21(2):186-203. PubMed ID: 32744973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review.
    Qin HL; Zhang ZW; Lekkala R; Alsulami H; Rakesh KP
    Eur J Med Chem; 2020 May; 193():112215. PubMed ID: 32179331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of selenophene-based chalcone analogs and assessment of their biological activity as anticancer agents.
    Chen YC; Li CW; Chen JJ; Shih TL
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200486. PubMed ID: 36587972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chalcone Derivatives and their Activities against Drug-resistant Cancers: An Overview.
    Xiao J; Gao M; Diao Q; Gao F
    Curr Top Med Chem; 2021; 21(5):348-362. PubMed ID: 33092509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer Active Heterocyclic Chalcones: Recent Developments.
    Dandawate P; Ahmed K; Padhye S; Ahmad A; Biersack B
    Anticancer Agents Med Chem; 2021; 21(5):558-566. PubMed ID: 32628595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
    Srinivasan B; Johnson TE; Lad R; Xing C
    J Med Chem; 2009 Nov; 52(22):7228-35. PubMed ID: 19883086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives.
    Guan YF; Liu XJ; Yuan XY; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Li W; Zhang SY
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
    Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
    Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
    Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
    Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Indole-Chalcone Inhibits Multidrug-Resistant Cancer Cell Growth by Targeting Microtubules.
    Cong H; Zhao X; Castle BT; Pomeroy EJ; Zhou B; Lee J; Wang Y; Bian T; Miao Z; Zhang W; Sham YY; Odde DJ; Eckfeldt CE; Xing C; Zhuang C
    Mol Pharm; 2018 Sep; 15(9):3892-3900. PubMed ID: 30048137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Fluorescence Properties of 4-Dialkylaminochalcones and Investigation of the Cytotoxic Mechanism of Chalcones.
    Zhou B; Jiang P; Lu J; Xing C
    Arch Pharm (Weinheim); 2016 Jul; 349(7):539-52. PubMed ID: 27214789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chalcone: A Privileged Structure in Medicinal Chemistry.
    Zhuang C; Zhang W; Sheng C; Zhang W; Xing C; Miao Z
    Chem Rev; 2017 Jun; 117(12):7762-7810. PubMed ID: 28488435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.